Devin Whittemore Smith

General Counsel, Minerva Neurosciences (United States).

Companies

IO Biotech, Inc.General counsel Jan 13, 2023 to now¹
Proteostasis Therapeutics (United States)General counsel Jun 16, 2021 to Dec 6, 2022²
Minerva Neurosciences (United States)General counsel Aug 2, 2018 to Oct 14, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Proteostasis Therapeutics (United States)13,961 shares⁴Dec 2, 2022
IO Biotech, Inc.16,938 shares⁵Dec 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 23, 2024Bought 12,000 shares at $0.81 of IO Biotech, Inc.⁵
Aug 9, 2023Granted 4,938 shares at $1.90 of IO Biotech, Inc.⁶
Dec 2, 2022Sold 3,116 shares at $1.69 of Proteostasis Therapeutics (United States)⁴
Jun 3, 2022Sold 2,923 shares at $1.19 of Proteostasis Therapeutics (United States)⁷
Dec 1, 2021Granted 20,000 shares of Proteostasis Therapeutics (United States)⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIO Biotech, Inc., General counsel
2
SEC EDGARProteostasis Therapeutics (United States), General counsel
3
SEC EDGARMinerva Neurosciences (United States), General counsel
4
SEC EDGARProteostasis Therapeutics (United States) shares after the filing of Dec 2, 2022
5
SEC EDGARIO Biotech, Inc. shares after the filing of Dec 23, 2024
6
SEC EDGARForm 4 filed Aug 9, 2023
7
SEC EDGARForm 4 filed Jun 6, 2022
8
SEC EDGARForm 4 filed Dec 3, 2021